[1]
“Oral Anticoagulants in Low-Risk Atrial Fibrillation Patients: A Population-Based Study”, ccm, vol. 4, no. 1, pp. 66–75, Feb. 2020, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/15791